Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial.

Lancet Infect Dis · 2026 · PMC13241577 · PMID 41713476

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

approaching significanceno p-value reported

However, in a secondary analysis that included all ETEC-positive MSD events regardless of copathogens, ETVAX prevented nearly half of ETEC-positive diarrhoea events, approaching significance.

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.